Alzheimer’s Association to host Advocacy Day
Hey savvy news reader! Thanks for choosing local.
You are now reading
1 of 3 free articles.
News from the Alzheimer’s Association Montana Chapter
MONTANA – On March 19, the Alzheimer’s Association Montana Chapter will host an Advocacy Day at the state capitol to discuss Alzheimer’s disease and related dementias, and their impact on Montana. According to the Alzheimer’s Association’s 2019 Alzheimer›s Disease Facts & Figures report, there are 21,000 people living with Alzheimer’s and 50,000 Alzheimer’s caregivers in Montana.
The Alzheimer’s Association Advocacy Day will provide opportunities for advocates to meet face-to-face with state elected officials. Advocates will share their personal stories of how Alzheimer’s has impacted their lives and make strategic requests of state policymakers.
“Alzheimer’s presents a growing public health crisis with a human impact that cannot be overstated. At Advocacy Day, Montanans impacted by Alzheimer’s and related dementias will come together in the true spirit of our citizen legislature to collaborate with lawmakers on strategies to address this significant challenge,” said Lynn Mullowney Cabrera, executive director of the Alzheimer’s Association Montana Chapter
In addition to the human toll of the disease, care for Alzheimer’s – the country’s most expensive condition – cost the nation $277 billion in 2018 with projections to reach $1.1 trillion by 2050. These staggering numbers do not include unpaid care by friends and family valued at $232 billion a year. State governments are increasingly on the front lines in addressing the Alzheimer’s crisis, the care and support needs of families facing the disease and its impact on local economies.
For more information on Alzheimer’s disease and dementia, call the Alzheimer’s Association toll-free, 24/7 helpline at 1-800-272-3900 or visit alz.org.
The Alzheimer’s Association is the leading voluntary health organization in Alzheimer’s care, support and research. Our mission is to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health.
